Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

Cytori appoints David Rickey as chairman

Replaces Lloyd Dean who will concentrate on CEO position at Dignity Health

- PMLiVE

The marketer’s role in early drug development

Why as a marketer you can do much to enable your R&D colleagues to find a product’s added value

- PMLiVE

EMA in firing line as transparency debate widens

Swedish regulator claims EU agency withheld information on drug withdrawn from sale in 2008

Wanted: Social media innovation to detect AEs

EU-pharma partnership seeks proposals on harnessing the power of the internet and social media to track adverse events

Roche - Basel

Late-stage blow to Roche’s diabetes ambitions

Halts development of aleglitazar on safety and efficacy concerns

- PMLiVE

GSK signs $500m-plus technology deal with Immunocore

Will make use of ImmTAC technology to activate immune system to kill cancerous or infected cells

- PMLiVE

GSK files combination skin cancer drug in US

Seeks FDA approval for Tafinlar - Mekinist combination in melanoma

AZ target Omthera files blood fat drug in US

FDA submission for Epanova in severe hypertriglyceridemia

- PMLiVE

Pfizer veteran joins Dynavax board

Natale Ricciardi spent 39 years at pharma giant

personalised patient support

Personalised patient support

An age of integration and patient-centricity in healthcare has emerged and the global pharma industry has an opportunity to be at the forefront of this change

- PMLiVE

GSK’s Botox sales in China under scrutiny says WSJ

Newspaper says it has reviewed company documents that discuss giving kickbacks to doctors to prescribe Botox

- PMLiVE

Rare diseases among initial priorities of UK DNA mapping body

Genomics England will also help advance research into cancer and infectious diseases

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links